Close

VistaGen Therapeutics (VTGN) Says EPO to Grant European Patent for AV-101

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. SPOT
5. V
6. BA
7. KMB
8. FI
9. SPY
10. MSCI


Go back to VistaGen Therapeutics (VTGN) Says EPO to Grant European Patent for AV-101
(NASDAQ: VTGN) Delayed: 4.73 -0.1 (2.07%)
Previous Close $4.83    52 Week High $4.60 
Open $4.85    52 Week Low $2.81 
Day High $4.86    P/E N/A 
Day Low $4.65    EPS $0.00 
Volume 117,109